At the endpoint, the levels of cleaved-caspase-3, Ki-67, VSV-G, and IRF3 were further examined in the subcutaneous xenograft tumor sections by immunohistochemistry (IHC) staining. The gene discussed is CASP3; the disease is neoplasm.